ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Imnovid 2 mg, Hartkapseln - 21 Kapsel(n)
61249002 Bristol-Myers Squibb SA
Imnovid 2 mg, Hartkapseln02.06.2014
  02.06.2014
Pomalidomide (L04AX06) 
WHO-DDD 
07.16.40.21 Kapsel(n)
07.16.40. 
A  
Yes 
IPCI
7916.10Yes
    
10 %8368.15
7680612490029Synthetika
6011068 
Composition
pomalidomidum 2 mg, mannitolum, amylum pregelificatum, natrii stearylis fumaras corresp. natrium 0.036 mg, Kapselhülle: gelatina, E 171, E 132, E 127, E 172 (flavum), Drucktinte: lacca, E 171, simeticonum, propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Pomalidomidum2 mg
BAG: Active AgentDose
Pomalidomidum2 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
Ammoniae Solutio28  
Amylum Pregelificatum  
E 127 color.
E 132 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Mannitol  
Natrii Stearylis Fumaras  
Per Centum  
Pro Capsula  
Propylenglycol  
Simeticone  
 
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home